Cystatin C, renal function and cardiovascular risk

Journal of Medical Biochemistry

Volumn 27, Issue 4, 2008, Pages 426-431

  Wagner, Carola ^a  

^a SIEMENS AG   (Germany)

Author keywords

Cardiovascular risk; Chronic kidney disease; Cystatin C; GFR

Indexed keywords

BIOLOGICAL MARKER; CYSTATIN C;

CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; CORRELATION ANALYSIS; CREATININE BLOOD LEVEL; DISEASE COURSE; GLOMERULUS FILTRATION RATE; HEART FAILURE; HUMAN; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; KIDNEY FUNCTION TEST; MORTALITY; PREDICTION; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEIN SECRETION; REVIEW; RISK ASSESSMENT;

EID: 56549130976     PISSN: 14528258     EISSN: 14528266     Source Type: Journal    
DOI: 10.2478/v10011-008-0021-4     Document Type: Review

References (22)

1. Tanaka A, Suemaru K, Araki H. A new approach for evaluating renal function and its practical application. J Pharmacol Sci 2007; 105: 1-5.
2. Jernberg T, Lindahl B, James S et al. Cystatin C - A novel predictor of outcome in suspected or confirmed non-ST-elevation acute coronary syndromes. Circulation 2004; 110: 2342-8.
3. Koenig W, Twardella D, Brenner H et al. Plasma concentrations of cystatin C in patients with coronary heart disease and risk for secondary cardiovascular events: More than simply a marker of glomerular filtration rate. Clin Chem 2005; 51: 321-7.
4. Shlipak MG, Sarnak MJ, Katz R et al. Cystatin C and the risk of death and cardiovascular events among elderly persons. N Engl J Med 2005; 352: 2049-60.
5. Levey AS, Atkins R, Coresh J et al. Chronic kidney disease as a global public health problem: Approaches and initiatives - a position statement from Kidney Disease Improving Global Outcomes. Kidney Int 2007; 72: 247-59.
6. Levey AS, Eckhardt KU, Tsukamoto Y et al. Definition and classification of chronic kidney disease: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 2005; 67: 2089-100.
7. Herget-Rosenthal S, Bökenkam A, Hofmann W: How to estimate GFR - serum creatinine, serum cystatin C or equations? Clin Biochem 2007; 40: 153-61.
8. Roos JF, Doust J, Tett SE et al. Diagnostic accuracy of cystatin C compared to serum creatinine for the estimation of renal dysfunction in adults and children - A metaanalysis. Clin Biochem 2007; 40: 383-91.
9. 2-microglobulin, and creatinine compared for detecting impaired glomerular filtration rates in children. Clin Chem 2002; 48: 729-36.
10. Fliser D, Ritz E. Serum cystatin C concentration as a marker of renal dysfunction in the elderly. Am J Kidney Dis 2001; 37: 79-83.
11. Perkins BA, Nelson RG, Ostrander BEP et al. Detection of renal function decline in patients with diabetes and normal or elevated GFR by serial measurement of serum cystatin C concentration: Results of a 4-year follow-up study. J Am Soc Nephrol 2005; 16: 1404-12.
12. Hoek FJ, Kemperman FAW, Krediet RT. A comparison between cystatin C, plasma creatinine and the Cockcroft and Gault formula for the estimation of glomerular filtration rate. Nephrol Dial Transplant 2003; 18: 2024-31.
13. Larsson A, Malm J, Grubb A et al. Calculation of glomerular filtration rate expressed in mL/min from plasma cystatin C values in mg/L. Scand J Clin Lab Invest 2004; 64: 25-30.
14. Beauvieux MC, Le Moigne F, Lasseur C et al. New predictive equations improve monitoring of kidney function in patients with diabetes. Diabetes Care 2007; 30: 1988-94.
15. Stevens LA, Coresh J, Schmid CH et al. Estimating GFR using serum cystatin C alone and in combination with serum creatinine: A pooled analysis Of 3,418 individuals with CKD. Am J Kidney Dis 2008; 51: 395-406.
16. Herget-Rosenthal S, Marggraf G, Hüsing J et al. Early detection of acute renal failure by serum cystatin C. Kidney Int 2004; 66: 1115-22.
17. Shlipak MG, Katz R, Sarnak MJ et al. Cystatin C and prognosis for cardiovascular and kidney outcomes in elderly persons without chronic kidney disease. Ann Intern Med 2006; 145: 237-46.
18. Sarnak MJ, Katz R, Stehman-Breen CO et al. Cystatin C concentration as a risk factor for heart failure in older adults. Ann Intern Med 2005; 142: 497-505.
19. Mijušković Z, Maksić DJ, Hrvačević R et al. Urinary Cysta tin C as a marker of tubular disfunction. Journal of Medical Biochemistry 2007; 26: 98-102.
20. Sarnak MJ, Katz R, Fried LF et al. Cystatin C and aging success. Arch Intern Med 2008; 168: 147-53.
21. Hillege HL, Verhave JC, Bakker SJL et al. Cystatin C is superior to serum creatinine in prediction of mortality in the general population; data obtained from the PREVEND study. ASN Congress 2003; abstract SA-FC150.
22. Kalansooriya A, Holbrook I, Jennings P et al. Serum cystatin C, enzymuria, tubular proteinuria and early renal insult in type 2 diabetes. Br J Biomed Sci 2007; 64: 121-3.